Table 2.
Change in bone mineral density after 12 months therapy with zoledronic acid
| Site | BMD change (g/cm2) Median (range) |
BMD change (%) Median (range) |
|---|---|---|
| Lumbar | 0.041 (− 0.073 to 0.162) | 5.4% (− 7 to 27.8%) |
| Hip | 0.016 (− 0.113 to 0.101) | 2.2% (− 12.4 to 13.4%) |
| Forearm | 0.010 (− 0.023 to 0.047) | 1.8% (− 5.9 to 9.9%) |
| Overall | 0.028 (− 0.113 to 0.162) | 3.2% (− 12.4 to 27.8%) |